Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
Lee Hilliard
Professor of Pediatrics
Close
E-mail
ponca@uab.edu
Links
Provider Directory
Visualizations
Co-investigator Network
Lee Hilliard
Professor of Pediatrics
Positions
Professor (P)
,
Pediatric - Hematology-Oncology
,
Pediatrics
1996 -
Research
Background
Contact
Research
Principal Investigator On
DISPLACE:Dissemination and Implementation of Stroke Prevention: Looking at The Care Environment
awarded by
Medical University of South Carolina
2017 - 2022
Private Grant
awarded by
SANCILIO & COMPANY, INC.
2017 - 2020
Prospective Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT Trial)
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
2017 - 2019
The Kids - DOTT Trial
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
2015 - 2017
TCD with Transfusions Changing to Hydroxyurea
awarded by
CINCINNATI CHILDREN'S HOSPITAL
2013 - 2015
Prevention of Stroke After STOP, A Retrospective Chart Review (Post STOP)
awarded by
Medical University of South Carolina
2012 - 2013
TCD with Transfusions Changing to Hydroxyurea
awarded by
Baylor College of Medicine
2011 - 2013
TCD with Transfusions Changing to Hydoxyurea (Twitch)
awarded by
St. Jude Children's Research Hospital
2009 - 2011
Stroke with Transfusions Changing to Hydroxyurea (SWITCH)
awarded by
St. Jude Children's Research Hospital
2005 - 2011
Investigator On
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2019 - 2025
Private Grant
awarded by
GLOBAL BLOOD THERAPEUTICS, INC.
2020 - 2025
Private Grant
awarded by
NOVARTIS PHARMACEUTICALS CORPORATION
2019 - 2025
DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
awarded by
National Heart, Lung, and Blood Institute/NIH/DHHS
2019 - 2022
Project EveryChild APEC14B1
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2017 - 2021
AALL1331: Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND#100135, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2015 - 2021
The COVID-19 Anticoagulation in Children-Thromboprophylaxis (COVAC-TP) Trial
awarded by
ALL CHILDREN'S RESEARCH INSTITUTE
2020 - 2021
Private Grant
awarded by
Pfizer Inc., U.S. Pharmaceuticals Group
2017 - 2020
A Phase 3 Randomized Trial for Newly Diagnosed High Risk B-precursor Acute Lymphoblastic Leukemia (ALL) Testing Clofarabine (IND# 73789, NSC # 606869) in the Very High Risk Stratum
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2014 - 2020
St. Baldrick's Foundation Supplemental Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2018 - 2020
Per Case Reimbursement: COG NCORP Research Base
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2017 - 2019
AAML 1031 - Bayer
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2017 - 2019
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2018 - 2019
Project Everychild APEC14B1
awarded by
CHILDREN'S ONCOLOGY GROUP
2015 - 2018
Per Case Reimbursement: COG NCORP Research Base
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2014 - 2018
St. Baldricks Fdn Supplemental Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2018
AHOD1331 A Randomized Phase III Study of Brentuximab Vedotin (IND#117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2016 - 2018
Intergroup Trial for Children or Adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab Efficacy and Safety in High Risk Patients
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2013 - 2017
CTSU: Phase II Supplemental Payments (N02-CM-62212)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2017
Public Health Surveillance for the Prevention of Complications of Bleeding and Clotting Disorders
awarded by
HEMOPHILIA OF GEORGIA
2015 - 2016
Novel Methods to Detect Gene-Environment Interactions in Treatment-Related Brain Tumors Among Childhood Cancer Survivors
awarded by
University of Wisconsin-Milwaukee
2015 - 2016
CCOP Per Case Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2013 - 2015
Hydroxyurea to Prevent CNS Complications of Sickle Cell Disease in Children
awarded by
Johns Hopkins University
2013 - 2015
BIQSFP-COG AALL1131 11XS189 Per Case Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2015
COG PCR - Per Case Reimbursement NIH National Clinical Trials Network (NCTN) Grant (U10CA180886) Successor to NIH COG Chair Grant (U10CA098543)
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2014 - 2015
Private Grant
awarded by
MILLENNIUM PHARMACEUTICALS, INC.
2014
AAML 1031 - A Phase III Randomized Trial for Patients with De Novo AML Using Bortezomib (NSC# 681239) and Sorafenib (BAY 43-9006, NSC# 724772) for Patients with High Allelic Ratio FLT2/ITD
awarded by
CHILDREN'S ONCOLOGY GROUP
2014
Pediatric Trial Network-Hydroxyuea/To 4
awarded by
Duke University
2012 - 2014
COG Per Case Reimbursement
awarded by
CHILDREN'S HOSPITAL (PHILADELPHIA)
2012 - 2014
Private Grant
awarded by
TERUMO BCT, INC.
2012 - 2013
Hydroxyurea to Prevent CNS Complications of Sickle Cell Disease in Children
awarded by
Johns Hopkins University
2011 - 2013
Baby HUG Follow-up Study II: Clinical Studies
awarded by
University of Texas Southwestern Medical Center at Dallas
2012
Background
Education And Training
Doctor of Medicine,
University of Mississippi
1990
Arkansas Children's Hospital, Internship
1991
Arkansas Children's Hospital, Residency
1993
UAB Hospital, Postdoctoral Fellowship
1996
Contact
Full Name
Lee
Hilliard